04 Jun 2020
Amgen launches Adalimumab biosimilar in SA
By Staff Writer
Amgen has launched a treatment for autoimmune diseases in both adults and children. Amgevita is a biosimilar medicine and contains the active substance adalimumab. This means that Amgevita is similar to the biological medicine that is authorised in South Africa. It is available for patients suffering from the following conditions: • Rheumatoid arthritis • Active...
